Nanobiosym (NBS) Pilot Validation Study of Gene-RADAR Nanotechnology Platform Point-of-Care (POC) for Prevention of Mother to Child Transmission (PMTCT) of HIV in Rwanda

In collaboration with the Rwandan Ministry of Health & National Research Laboratory, and our on the ground implementing partners, Nanobiosym will reduce HIV related deaths in infants by scaling up access to its novel POC nanodiagnostic platform by validating Nanobiosym's proprietary Point-of-Care Gene-RADAR® diagnostic platform's ability to measure HIV positive mothers' viral load thereby ensuring they are responding to ART and reducing their chances of transmitting HIV to their child in-utero, at birth, or during the breastfeeding period.